1-7 of 7
Muneo Inaba
Close
Sort by
Journal Articles

Elotuzumab Enhances the Th2-Mediated Immune Response of Dendritic Cell Induced By Immunomodulatory Drugs (IMiDs)

Yoshiko Azuma, MD, Tomoki Ito, MD PhD, Muneo Inaba, PhD, Kai Imai, MD, Masaaki Hotta, MD, Atsushi Satake, MD PhD, Shosaku Nomura, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4342.
https://doi.org/10.1182/blood-2019-129680
Published: 2019
Journal Articles

Myeloma Cells Have the Ability to Suppress Th1-Inducing Capacity but Enhance Th2-Mediated Response of Dendritic Cells By Producing Factors Other Than Soluble SLAMF7

Yoshiko Azuma, MD, Tomoki Ito, MD PhD, Muneo Inaba, PhD, Kai Imai, MD, Hideaki Yoshimura, MD, Masaaki Hotta, MD, Takahisa Nakanishi, MD PhD, Shinya Fujita, MD PhD, Aya Nakaya, MD PhD, Atsushi Satake, MD PhD, Kazuyoshi Ishii, MDMPH,PhD, Shosaku Nomura, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1938.
https://doi.org/10.1182/blood-2018-99-113282
Published: 2018
Journal Articles

Lenalidomide Acts As a Positive Immunomodulator through Modulating the Functions of Human Plasmacytoid Dendritic Cells

Tomoki Ito, MD PhD, Kayoko Kibata, MD, Muneo Inaba, PhD, Yoshiko Azuma, MD, Yukie Tsubokura, MD, Hideaki Yoshimura, MD, Masaaki Hotta, MD, Takahisa Nakanishi, MD PhD, Shinya Fujita, MD PhD, Aya Nakaya, MD PhD, Atsushi Satake, MD PhD, Kazuyoshi Ishii, MDMPH,PhD, Shosaku Nomura, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1007.
https://doi.org/10.1182/blood.V130.Suppl_1.1007.1007
Published: 2017
Journal Articles

Immunomodulatory Drugs (IMiDs), Lenalidomide and Pomalidomide, Suppress Th1-Inducing Capacity of Dendritic Cells but Enhance Th2-Mediated Allergic Response

Tomoki Ito, M. D. and Ph. D., Phan Thi Xuan Vien, Muneo Inaba, Ph. D, Hideaki Yoshimura, MD, Masaaki Hotta, MD, Takahisa Nakanishi, MD PhD, Shinya Fujita, MD PhD, Aya Nakaya, MD PhD, Atsushi Satake, MD PhD, Kazuyoshi Ishii, MD MPH, PhD, Shosaku Nomura, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2520.
https://doi.org/10.1182/blood.V128.22.2520.2520
Published: 2016
Journal Articles

Intra–bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice

Taketoshi Kushida, Muneo Inaba, Hiroko Hisha, Naoya Ichioka, Takashi Esumi, Ryokei Ogawa, Hirokazu Iida, Susumu Ikehara
Journal: Blood
Blood (2001) 97 (10): 3292–3299.
https://doi.org/10.1182/blood.V97.10.3292
Published: 2001
Journal Articles

Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation

Taketoshi Kushida, Muneo Inaba, Kenji Takeuchi, Kikuya Sugiura, Ryokei Ogawa, Susumu Ikehara
Journal: Blood
Blood (2000) 95 (5): 1862–1868.
https://doi.org/10.1182/blood.V95.5.1862.005k27_1862_1868
Published: 2000
Journal Articles

A New Strategy for Treatment of Autoimmune Diseases in Chimeric Resistant MRL/lpr Mice

Kenji Takeuchi, Muneo Inaba, Shigeo Miyashima, Ryokei Ogawa, Susumu Ikehara
Journal: Blood
Blood (1998) 91 (12): 4616–4623.
https://doi.org/10.1182/blood.V91.12.4616
Published: 1998